Announcement, From Bench to Fireside 12.13.23 Share on Twitter Share on Facebook Share on LinkedIn From Cancer Care in New York City to Next-Gen Immunotherapies with Jedd D. Wolchok, MD, PhD This episode of “From Bench to Bedside” is a special one for PICI that marks a network expansion, with Weill Cornell Medicine joining as our newest PICI Center. The collaboration will build upon PICI’s work to accelerate research efforts in cancer immunotherapy. Dr. Jedd D. Wolchok, the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine and newly appointed Center Director for the PICI Center at Weill Cornell Medicine talks with PICI’s Chief Scientific Officer John Connolly, PhD, to discuss the new cancer immuno-oncology research center in NYC. Dr. Wolchok, who previously served as PICI Center Director at Memorial Sloan Kettering Cancer Center (MSKCC), shares his vision for the PICI Center at Weill Cornell, ideas for integrating clinical research and cancer care to improve access for diverse populations, ambitions to accelerate cancer immunotherapy research, and two-decade exploration of immunity’s interaction with cancer. He also dives into challenges targeting checkpoint inhibitors, advancements in manufacturing cell therapies, personalized cancer vaccines, and the potential of engineered cytokines in next-gen immunotherapies. Dr. Wolchok shares his strategic approach to guiding the strategic direction of the PICI Center at Weill Cornell Medicine. He delves into integrating clinical research and cancer care to enhance access for diverse populations and his ambitious plans for expediting cancer immunotherapy research. His extensive knowledge draws from more than two decades of researching the intricate interplay between the immune system and cancer. The conversation extends to the challenges associated with targeting checkpoint inhibitors, the latest advancements in manufacturing cell therapies, and the promising realm of personalized cancer vaccines. Dr. Wolchok also sheds light on the potential of engineered cytokines in shaping the landscape of next-generation immunotherapies. Get ready to go from bench to fireside with Dr. Jedd Wolchok as he shares his bold vision for the future of the field. Listen on Spotify Related Announcement, Press Release Parker Institute Awards $525,000 to Advance Diverse Talent in Cancer Research Announcement PICI Network Investigators Propel Immunotherapy Progress at SITC 2024 Announcement, Press Release PICI’s 2024 Fall Scientific Retreat Ignites Collaboration to Accelerate Cancer Immunotherapy
Announcement, Press Release Parker Institute Awards $525,000 to Advance Diverse Talent in Cancer Research
Announcement, Press Release PICI’s 2024 Fall Scientific Retreat Ignites Collaboration to Accelerate Cancer Immunotherapy